<DOC>
	<DOC>NCT00820794</DOC>
	<brief_summary>The purpose of this study is to investigate if PD 0332334 affects the pharmacokinetics of lithium by co-administering both drugs to healthy adults.</brief_summary>
	<brief_title>A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects</brief_title>
	<detailed_description>Additional Study Purpose Details: To investigate potential drug-drug interaction between PD 0332334 and lithium</detailed_description>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Healthy males and/or females Age from 21 to 55 (inclusive) BMI ranges from 18 to 30 kg/m2 Previous participation in a PD 332334 study Pregnant or nursing females Hypersensitivity (allergic) to lithium, Neurontin (gabapentin), or Lyrica (pregabalin)</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Drug-drug interaction, lithium, PD 0332334, pharmacokinetics</keyword>
</DOC>